The board of directors should have someone with sufficient background and subject matter expertise to be able to read the description of a technology the board is considering and say, "wait a minute, this sounds too good to be true." That should trigger due diligence, which can involve, among other things, sending an outside party to audit Theranos.

The fact that Walgreens has no such person on their board is their failing, in my opinion.